The Effect of Fenofibrate and Exercise on Metabolic Syndrome and Hepatic Steatosis in OLETF Rats.

Kyung II Lee; Ji Min Kim; Ja Young Park; Ja Won Kim; Ji Young Mok; Mi Kyoung Park; Hye Jeong Lee; Sook Hee Hong; Wenjun Li; Duk Kyu Kim

doi:10.3803/jkes.2007.22.3.192

Articles

Page Path: HOME > Endocrinol Metab > Volume 22(3); 2007 > Article

Original Article The Effect of Fenofibrate and Exercise on Metabolic Syndrome and Hepatic Steatosis in OLETF Rats.: Kyung II Lee, Ji Min Kim, Ja Young Park, Ja Won Kim, Ji Young Mok, Mi Kyoung Park, Hye Jeong Lee, Sook Hee Hong, Wenjun Li, Duk Kyu Kim; Endocrinology and Metabolism 2007;22(3):192-202
DOI: https://doi.org/10.3803/jkes.2007.22.3.192
Published online: June 1, 2007

2,125 Views
22 Download
1 Crossref
0 Scopus

¹Department of Internal Medicine, College of Medicine,Dong-A University, Korea.
²Department of Pharmacology, College of Medicine,Dong-A University, Korea.
³Department of Pathology, College of Medicine,Dong-A University, Korea.
⁴Medical Sciences Research Institutes, College of Medicine,Dong-A University, Korea.
⁵Department of Internal Medicine, Baptist Hospital, Korea.
⁶Department of Internal Medicine, Suyeong Hanseo Hospital, Korea.
⁷Center for Human Nutrition, University of Texas Southwestern Medical Center, USA.

Full Article

Download PDF

Abstract

BACKGROUND
The aim of this study is to verify the effects of fenofibrate monotherapy and fenofibrate combined with exercise for improving metabolic syndrome and hepatic steatosis. METHODS: Thirty-four weeks old OLETF rats (Otsuka Long-Evans Tokushima Fatty Rats, n = 20) were divided four groups: the regular diet group (n = 5, DD group), the exercise group (n = 5, DE group), the fenofibrate (100 mg/kg) treated group (n = 5, DF group) and the combination treatment group {fenofibrate and exercise (n = 5, EF group)}. After 5 weeks of treatment, blood was drawn for measuring the blood glucose, insulin, lipid and leptin levels. All the subjects were sacrificed for assessment of their body adiposity and hepatic steatosis. RESULTS: The total amount of food intake, body weight and total body weight of the rat were significantly decreased in the EF and DF groups compared to the DD group. The plasma triglyceride and glucose levels were significantly decreased in the EF and DF groups compared to the DD group. The HOMA-IR of EF, DF and DE groups were significantly decreased compared with that of the DD group. The plasma leptin levels of the EF and DF groups were significantly decreased compared with those of the DD and DE groups. The hepatic steatosis index was significantly decreased in the EF and DF groups compared to the DD and DE groups. CONCLUSION: Fenofibrate monotherapy was effective to control three major components (obesity, hypertriglyceridemia and hyperglycemia) of metabolic syndrome and hepatic steatosis in OLETF rats. Exercise combined with fenofibrate treatment showed an additional effect compared to that of fenofibrate monotherapy.

Keywords: Adiposity;Exercise;Fenofibrate;Insulin resistance;Leptin;Metabolic syndrome;Steatosis;

Figure & Data

References

Citations

Citations to this article as recorded by

Effect of Fenofibrate and Exercise on Metabolic Syndrome and Hepatic Steatosis
Bong Soo Cha, Jae Hyuk Lee
Journal of Korean Endocrine Society.2007; 22(3): 188. CrossRef

Cite

Related articles